Abstract
Gene therapy holds great promise for the treatment of disease by delivering genes encoding for therapeutic proteins. Although it was originally devised for the treatment of inherited genetic disorders, such as cystic fibrosis, recent work has expanded the applications of gene therapy to develop strategies for HIV, cancer (1), and wound healing applications (2). The challenge of gene therapy is to develop safe and efficient gene delivery systems (1). Most studies have focused on the use of viral vectors because of their potentially high efficiencies; however, the safety and ease of manufacturing of nonviral vectors may make them the preferred choice in the future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson W. F. (1998) Human gene therapy. Nature 392, 25–30.
Bonadio J., Goldstein S. A., and Levy R. J. (1998) Gene therapy for tissue repair and regeneration. Adv. Drug Delivery Rev. 33, 53–69.
Ledley F. D. (1996) Pharmaceutical approach to somatic gene therapy. Pharm. Res. 13, 1595–1614.
Ledley F. D. (1995) Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6, 1129–1144.
Luo D. and Saltzman W. M. (2000) Synthetic DNA delivery systems. Nat. Biotechnol. 18, 33–37.
Langer R. (1998) Drug delivery and targeting. Nature 392, 5–10.
Sanders L. M., Kell B. A., McRae G. I., and Whitehead G. W. (1986) Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. J. Pharm. Sci. 75, 356–360.
Takakura Y., Mahato R. I., and Hashida M. (1998) Extravasation of macromolecules. Adv. Drug Delivery Rev. 34, 93–108.
Choate K. A. and Khavari P. A. (1997) Direct cutaneous gene delivery in a human genetic skin disease. Hum. Gene Ther. 8, 1659–1665.
Levy M. Y., Barron L. G., Meyer K. B., and Szoka F. C., Jr. (1996) Characterization of plasmidDNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 3, 201–211.
Kawabata K., Takakura Y., and Hashida M. (1995) Fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12, 825–830.
Baldwin S. P. and Saltzman W. M. (1998) Materials for protein delivery in tissue engineering. Adv. Drug Delivery Rev. 33, 71–86.
Hedley M. L., Curley J., and Urban R. (1998) Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. 4, 365–368.
Wang D., Robinson D. R., Kwon G. S., and Samuel J. (1999) Encapsulation of plasmid DNA in biodegradable poly(¢D,¢L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J. Controlled Release 57, 9–18.
Jones D. H., Corris S., McDonald S., Clegg J. C., and Farrar G. H. (1997) Poly(¢D,¢L-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 15, 814–817.
Luo D., Woodrow-Mumford K., Belcheva N., and Saltzman W. M. (1999) Controlled DNA delivery systems. Pharm. Res. 16, 1300–1308.
Ochiya T., Takahama Y., Nagahara S., Sumita Y., Hisada A., Itoh H., Nagai Y., and Terada M. (1999) New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat. Med. 5, 707–710.
Mathiowitz E., Jacob J. S., Jong Y. S., Carino G. P., Chickering D. E., Chaturvedi P., et al. (1997) Biologically erodable microspheres as potential oral drug delivery systems. Nature 386, 410–414.
Shea L. D., Smiley E., Bonadio J., and Mooney D. J. (1999) DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17, 551–554.
Bonadio J., Smiley E., Patil P., and Goldstein S. (1999) Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753–759.
Middaugh C. R., Evans R. K., Montgomery D. L., and Casimiro D. R. (1998) Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci. 87, 130–146.
Pachence J. M. (1996) Collagen-based devices for soft tissue repair. J. Biomed. Mater. Res. 33, 35–40.
Schoen F. J. and Levy R. J. (1999) Tissue heart valves: current challenges and future research perspectives. J. Biomed. Mater. Res. 47, 439–465.
Wong W. H. and Mooney D. J. (1997) Synthesis and properties of biodegradable polymers used as synthetic matrices for tissue engineering, in Synthetic Biodegradable Polymer Scaffolds (Atala A. and Mooney D. J., eds.), Birkhauser, Boston, pp. 49–80.
Peppas N. A. and Langer R. (1994) New challenges in biomaterials. Science 263, 1715–1720.
Muggli D. S., Burkoth A. K., and Anseth K. S. (1999) Crosslinked polyanhydrides for use in orthopedic applications: degradation behavior and mechanics. J. Biomed. Mater. Res. 46, 271–278.
Cleland J. L., Powell M. F., and Shire S. J. (1993) The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation [published erratum appears in Crit. Rev. Ther. Drug Carrier Syst. 1994;11:60]. Crit. Rev. Ther. Drug Carrier Syst. 10, 307–377.
Putney S. D. and Burke P. A. (1998) Improving protein therapeutics with sustained-release formulations [published erratum appears in Nat. Biotechnol. 1998 16:478]. Nat. Biotechnol. 16, 153–157.
Adami R. C., Collard W. T., Gupta S. A., Kwok K. Y., Bonadio J., and Rice K. G. (1998) Stability of peptide-condensed plasmid DNA formulations. J. Pharm. Sci. 87, 678–683.
Capan Y., Woo B. H., Gebrekidan S., Ahmed S., and DeLuca P. P. (1999) Preparation and characterization of poly (¢D,¢L-lactide-co-glycolide) microspheres for controlled release of poly(¢L-lysine) complexed plasmid DNA. Pharm. Res. 16, 509–513.
Capan Y., Woo B. H., Gebrekidan S., Ahmed S., and DeLuca P. P. (1999) Influence of formulation parameters on the characteristics of poly(¢D,¢L-lactideco-glycolide) microspheres containing poly(¢L-lysine) complexed plasmid DNA. J. Controlled Release 60, 279–286.
Ando S., Putnam D., Pack D. W., and Langer R. (1999) PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J. Pharm. Sci. 88, 126–130.
Jong Y. S., Jacob J. S., Yip K., Gardner G., Seitelman E., Whitney M., Montgomery S., and Mathiowitz E. (1997) Controlled release of plasmid DNA. J. Controlled Release 47, 123–134.
Fang J., Zhu Y. Y., Smiley E., Bonadio J., Rouleau J. P., Goldstein S. A., et al. (1996) Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. USA 93, 5753–5758.
Harris L. D., Kim B. S., and Mooney D. J. (1998) Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mater. Res. 42, 396–402.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Shea, L.D., Mooney, D.J. (2001). Nonviral DNA Delivery from Polymeric Systems. In: Findeis, M.A. (eds) Nonviral Vectors for Gene Therapy. Methods in Molecular Medicine™, vol 65. Humana Press. https://doi.org/10.1385/1-59259-139-6:195
Download citation
DOI: https://doi.org/10.1385/1-59259-139-6:195
Publisher Name: Humana Press
Print ISBN: 978-0-89603-712-0
Online ISBN: 978-1-59259-139-8
eBook Packages: Springer Protocols